Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

BCEL

Atreca (BCEL)

Atreca Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:BCEL
일자시간출처헤드라인심볼기업
2020/03/2007:53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
2020/03/1205:48Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:BCELAtreca Inc
2020/03/1205:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BCELAtreca Inc
2020/03/1205:30GlobeNewswire Inc.Atreca Reports Fourth Quarter and Full Year 2019 Financial ResultsNASDAQ:BCELAtreca Inc
2020/03/1205:19Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BCELAtreca Inc
2020/03/0508:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
2020/02/2908:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
2020/02/2908:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
2020/02/2907:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
2020/02/2708:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
2020/02/2506:30GlobeNewswire Inc.Atreca to Present at the Cowen and Company 40th Annual Health Care ConferenceNASDAQ:BCELAtreca Inc
2020/02/1507:40Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BCELAtreca Inc
2020/02/1507:39Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BCELAtreca Inc
2020/02/1506:48Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BCELAtreca Inc
2020/02/1504:20Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BCELAtreca Inc
2020/02/1406:30GlobeNewswire Inc.Atreca Announces First Patient Dosed in Phase 1b Clinical Trial of ATRC-101 in Patients with Select Solid TumorsNASDAQ:BCELAtreca Inc
2020/02/1305:30Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BCELAtreca Inc
2020/02/0606:05GlobeNewswire Inc.Atreca Announces Strategic Research Collaboration with Merck to Identify Novel Antibody Targets in OncologyNASDAQ:BCELAtreca Inc
2019/12/0322:00GlobeNewswire Inc.Atreca Announces FDA Clearance of Investigational New Drug Application for ATRC-101NASDAQ:BCELAtreca Inc
2019/11/1422:00GlobeNewswire Inc.Atreca to Present at Two Upcoming Investor ConferencesNASDAQ:BCELAtreca Inc
2019/11/1306:05GlobeNewswire Inc.Atreca Reports Third Quarter 2019 Financial Results and Recent Corporate DevelopmentsNASDAQ:BCELAtreca Inc
2019/11/0522:00GlobeNewswire Inc.Atreca to Highlight ATRC-101 Preclinical Data at the 2019 Society for Immunotherapy of Cancer (SITC) Annual MeetingNASDAQ:BCELAtreca Inc
2019/08/2705:05GlobeNewswire Inc.Atreca Announces Appointment of Dr. Lindsey Rolfe to its Board of DirectorsNASDAQ:BCELAtreca Inc
2019/08/1405:05GlobeNewswire Inc.Atreca Reports Second Quarter 2019 Financial Results and Recent Corporate DevelopmentsNASDAQ:BCELAtreca Inc
2019/07/1121:00GlobeNewswire Inc.Atreca Further Strengthens Management Team with Appointment of Lisa Decker as Chief Business Officer and Courtney Phillips as...NASDAQ:BCELAtreca Inc
2019/06/2010:40GlobeNewswire Inc.Atreca Announces Pricing of Initial Public OfferingNASDAQ:BCELAtreca Inc
 검색 관련기사 보기:NASDAQ:BCEL